Transformer and Rectifier (India) Ltd: Q4FY17 Result Update

Similar documents
PNC Infratech Ltd.: Q3FY18 Result Update

Ujjivan Financial Services Ltd.: Q3FY18 Result Update

Jindal Stainless Hisar Ltd.: Q3FY18 Result Update

Dilip Buildcon Ltd.: Q3FY18 Result Update

Trident Ltd: Q2FY18 Result Update

Trident Ltd.: Q1FY18 Result Update

Economic Spotlight. Current Account Deficit Narrows. Edelweiss Investment Research

Economic Spotlight. Revised Govt. Borrowing Means More Fiscal Room. Edelweiss Investment Research

Ratnamani Metals & Tubes Ltd.: Q1FY18 Results Update

RELIANCE INDUSTRIES LIMITED

Zee Learn Ltd.: Q2FY18 Result Update

JSW Steel EDELSTAR FUNDAMENTAL RESEARCH

Kirloskar Brothers Ltd.: Q1FY18 Result Update

Emami Ltd. EDELSTAR FUNDAMENTAL RESEARCH

First Flash: Butterfly Gandhimathi Appliances Ltd

Kirloskar Brothers Ltd.: Q4FY17 Result Update

Performance Tracker Equity

S P Apparels Ltd.: Q2FY18 Result Update

S.P.Apparels Ltd. Q1FY18 Result Update

Edelweiss Investment Research Stock view: Axis Bank Ltd. Axis Bank Ltd.

Visaka Industries Ltd

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Cummins India Ltd Bloomberg Code: KKC IN

Fineotex Chemical Ltd

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Amber Enterprises India Ltd

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

Jamna Auto Industries

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

Adani Ports & SEZ Rating: Target price: EPS:

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Institutional Equities

Change EPS. (Rs) FY

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Robust results, TLT margins improved profitability.

HCL Technologies. Rating: Target price: EPS: Target CMP. Rating. Rs. 826 REDUCE. Rs.760

BUY MULTI COMMODITY EXCHANGE OF INDIA. Demonetization,GST uncertainty impact Q4. Target Price: Rs 1,397. Concall highlights

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

Key estimate revision. Year FY14 23,28,609 3,48,027 1,40, FY15E 25,74,029 3,94,133 1,69,

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Sanghvi Movers Ltd. Results above estimates. Figure 1: Actual Vs Religare Estimates. Financial highlights. Valuations and Recommendation

BUY MULTI COMMODITY EXCHANGE OF INDIA. Strong Q2; All eyes on option volumes. Target Price: Rs 1,280. Concall highlights

Simplex Infrastructures

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

BUY. Robust quarter with clear growth visibility DILIP BUILDCON. Target Price: Rs 610. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

Colgate-Palmolive (India)

Skipper Ltd. May 17, Towering high. CMP INR 205 Target INR 238 Result Update - BUY. Company Background. Investment Rationale

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

Gillette India. Institutional Equities. 1QFY18 Result Update

Ahluwalia Contracts (India)

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

He is BTech from IIT Bombay ( , Aeronautical Engineering) and MS from Cornell University ( , Mechanical Engineering).

Nestlé India Outlook Hazy; Valuations Prohibitive

ITC. Rating: Target price: EPS: Relative better visibility despite the smoke, Maintain BUY CMP. Target. Rating. Rs.389. Buy. Rs.

BUY. Outperformance continues GULF OIL LUBRICANTS INDIA. Target Price: Rs 1,000. Hike estimates and TP; maintain BUY

Key estimate revision. Financial summary. Year

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

Wipro. 4QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 287. Recommendation: Hold

Initiating Coverage. Uflex Ltd.

Symphony Ltd. RESULT UPDATE 31st October 2017

Dr Reddy s Laboratories

HINDUSTAN UNILEVER Indulekha allure for the tresses

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Key estimate revision. Year CY14 87,383 11,148 6, CY15E 1,20,126 17,838 9,

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Indian Oil Corporation

Balkrishna Industries

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Maruti Suzuki. Source: Company Data; PL Research

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Mahindra & Mahindra Ltd.

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Skipper Ltd. February 13, Towering high. CMP INR 153 Target INR 184 Result Update - BUY. Company Background. Investment Rationale

Wipro. 3QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 328. Recommendation: Hold

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

ITC Ltd. RESULT UPDATE 27th October, 2017

Transcription:

Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 Edelweiss Investment Research Transformer and Rectifier (India) Ltd: Q4FY17 Result Update Tepid order inflow led to revenue fall CMP INR 391 Target INR 446 Rating: BUY Upside: 14% TRIL s revenue INR 188 crore in Q4FY17 was down by -24.1% on YoY and below to our estimates by -13% due to change in product mix as proportion of low value products increased in the last quarter. EBITDA INR 21 crore fell by -22.7% YoY due to fall in topline while ebitda margins improved by 20 bps led by improvement in gross margins. The overall EBITDA is almost inline to our estimates. TRIL has reported exceptional items of INR 12.6 crore, a provision for doubtful debtors. Reported Adj. PAT (before exceptional items) grew by 19.6% due to increase in other income and fall in interest cost (reducing capital costs) in the last quarter. We expect a revenue and EBITDA CAGR of 10.4% and 17.7% over the period of FY17-19E.. Robust order book (INR 962 crore), 1.2x bill to book ratio TRIL s current order backlog stands at INR 962 crore (30,235 MVA), imparts robust revenue visibility over next 1.2 years. The current orderbacklog breakup comprises of Power Grid (23%), GETCO (23%), Renewable (15%), Export (10%) and others (29%). TRIL reported an order inflow of INR 915 crore for FY17 backed by PGCIL, State Transcoms and Renewable projects. Majority of orderbacklog belongs to 400kV - 765kV range that comprises more profitability. We expect a sustainable investment in sectors like Solar Power (10,000MVA/ year), Railways (INR 1,31,000 crore/year), Steel (INR 40,000 crore/year) and incremental spending by State Transcoms (INR 30,000 crore/ year) over the next 3-4 years will drive incremental demand for Power Transformers. Ankush Mahajan Research Analyst ankush.mahajan@edelweissfin.com Debashish Mazumdar Research Analyst debashish.mazumdar@edelweissfin.com Bloomberg: TRIL:IN 52-week range (INR): 476 / 281 Share in issue (cr): 1.3 M cap (INR cr): 518 Slight improvement in working capital The overall working capital cycle has improved to 137 days (from 143 days) due to improvement in Transcoms liquidity conditions and high proportion of private projects in product mix for FY17. However, debt levels have increased to INR 184 crore (from INR 155 crore) due to increase in working capital by INR 65 crore as company revenue grew by 38% on YoY. We expect, the company needs minimal working capital of INR 20-25 crore per year due to moderate topline growth and further improvement in payments from clients. Avg. Daily Vol. BSE/NSE :( 000): 10.6/40.4 Outlook and valuations: The Intrastate investment in T&D by State Transcoms and Government thrusts on Solar Power generation has created incremental demand of transformers and expected to continue for next 3-4 years. TRIL orderbacklog is gaining traction due to above factors and expect to deliver revenue and PAT CAGR of 10.4% and 80% respectively over FY17-19E. Further, TRIL already has announced to raise INR 125 crore via QIP. This indicates that company could go ahead for QIP in coming quarters. The hangover of equity dilution via QIP is still there. Public, 25.1 Promoter, 74.9 We revise our estimates to EPS INR 24.7 (from INR 30) for FY18E and added EPS of INR 31.8 for FY19E. At CMP of INR 391, TRIL is trading at PE of 12.3x of FY19E EPS of INR 31.8. We recommend BUY with target price of INR 446 (14.0% upside) after discounting FY19E EPS by 14x. Year to March (INR Cr) Q4FY17 Q4FY16 YoY (%) Q3FY17 QoQ (%) FY17 FY18E FY19E Net Rev enue 188 248-24% 192-2% 802 881 978 Rev enue Growth(%) 39% 10% 11% EBITDA 21 28-23% 16 34% 76 90 106 EBITDAM (%) 11% 11% 8% 10% 10% 11% Adj. PAT 13 11-2 - 13 33 42 Growth(%) - 151% 29% Adj. Diluted EPS (INR) 9.7 8.1 1.8 10 25 32 Diluted P/E (x) 39.8 15.8 12.3 EV/EBITDA (x) 8.9 7.5 6.3 RoCE (%) 13 14 16 180 160 140 120 100 80 60 40 TRIL Sensex Date: 9 th May 2017 1 GWM

Transformer and Rectifier (India) Ltd. Q4FY17 Result Highlights (INR Cr) Q4FY17 Q4FY16 YoY (%) Q3FY17 QoQ (%) FY18E FY17 %Change Net Revenues 188 248-24% 192-2% 881 802-9% Operating Expenses 167 220-24% 176-5% 791 726-8% EBITDA 21 28-23% 16 34% 90 76-15% Depreciation 3 3-5% 3-8% 14 13-6% EBIT 18 24-25% 12 45% 76 63-17% Interest expenses 8 10-14% 9-11% 33 36 10% Other income 4 2 130% 1-7 7 0% PBT 14 16-16% 4-49 33-32% Tax 1 5-86% 1-16 8-53% Reported PAT 13 11 20% 2-33 26-22% EoI 13 0-0 - 0 13 - Adj. PAT aft EoI 0.29 11-2 - 33 13 - Equity Capital 13.3 13.3 13.3 13.3 13.3 No of Shares 1.3 1.3 1.3 1.3 1.3 EPS 0.2 8.1 1.8 24.7 9.8 EBITDA Margin 11.3% 11.1% 8.3% 10.2% 9.5% PAT Margin 0.2% 4.3% 1.2% 3.7% 1.6% Tax Rate 5.4% 33.5% 38.3% 33.4% 23.1% (INR Cr) Q4FY17 Q4FY16 YoY (%) Q3FY17 QoQ (%) Revenues 188 248-24.1% 192-1.8% EBITDA 21 28-22.7% 16 33.9% EBITDAM (%) 11.3% 11.1% 8.3% Adj. PAT 12.8 10.7 19.6% 2.4 - Order backlog 962 846 13.7% 960 0.2% Order Inflow 190 160 19% 203-6.2% 2 GWM

Transformer and Rectifier (India) Ltd. Company Background TRIL, incorporated in 1994, manufactures power, distribution, furnace and specialty transformers. The company has three manufacturing facilities in Changodhar, Odhav and Moraiya. Currently, it has the second-largest installed capacity (33,000 MVA) in India. SEBs, PGCIL and NTPC are major clients and comprise ~85% of the company s overall order backlog (33-765 kv). TRIL s current order book stands at INR 868 cr (30,761 MVA), ~1.5x TTM sales. Product Portfolio Type of Transformer Power Transformer Distribution Transformer Range 33 kv to 765 kv (5 MVA to 500 MVA) 11KV to 33KV (0.315 MVA to 5 MVA) Substantial 85% revenue contributed by power transformers Distribution Transformer 15% Revenue Breakup (FY17) Power Transformer 85% Source: Company, Edelweiss Investment Research 3 GWM

Transformer and Rectifier (India) Ltd. Financials Income Statement (INR cr) Balance Sheet (INR cr) Profit & Efficiency Ratios Year to March FY15 FY16 FY17 FY18E FY19E As on 31st March FY15 FY16 FY17 FY18E FY19E Year to March FY15 FY16 FY17 FY18E FY19E Income from operations 542 576 802 881 978 Equity share capital 13 13 13 13 13 ROAE (%) -2-3 4 9 10 Direct costs 431 464 619 672 741 Warrants 0 0 0 0 0 ROACE (%) 3 4 13 14 16 Employee costs 23 23 27 35 39 Reserves & surplus 315 307 319 350 391 Debtors (days) 159 190 162 160 160 Other expenses 61 61 80 84 93 Shareholders funds 328 320 333 364 404 Current ratio 2 2 2 2 2 Total operating expenses 515 548 726 791 873 Secured loans 138 141 170 160 160 Debt/Equity 0 0 1 0 0 EBITDA 27 29 76 90 106 Unsecured loans 12 14 14 14 14 Inventory (days) 105 114 84 84 84 Depreciation and amortisation 12 13 13 14 15 Borrowings 150 155 184 174 174 Payable (days) 159 190 162 160 160 EBIT 15 15 63 76 91 Minority interest 0 0 0 0 0 Cash conversion cycle (days) 105 114 84 84 84 Interest expenses 28 33 36 33 32 Sources of funds 485 480 519 542 582 Debt/EBITDA 6 5 2 2 2 Other income 4 5 7 7 5 Gross block 229 236 250 265 280 Adjusted debt/equity 0 0 1 0 0 Profit before tax -10-13 33 49 63 Depreciation 54 68 81 95 111 Provision for tax -3-4 8 16 21 Net block 175 168 169 170 170 Valuation parameters Core profit -7-9 26 33 42 Capital work in progress 11 11 5 5 5 Year to March FY15 FY16 FY17 FY18E FY19E Extraordinary items 0 0-13 0 0 Total fixed assets 186 179 174 175 175 Diluted EPS (INR) -5-7 10 25 32 Profit after tax -7-9 13 33 42 Goodwill 0 0 0 0 0 Y-o-Y growth (%) NA NA NA 151 29 Minority Interest 0 0 0 0 0 Investments 6 6 6 6 6 CEPS (INR) 4 3 20 35 43 Share from associates 0 0 0 0 0 Inventories 156 180 184 203 225 Diluted P/E (x) NA NA 39.8 15.8 12.3 Adjusted net profit -7 9 13 33 42 Sundry debtors 236 300 356 386 429 Price/BV(x) 0.9 1.6 1.6 1.4 1.3 Equity shares outstanding (Crore) 1 1 1 1 1 Cash and equivalents 33 34 23 17 29 EV/Sales (x) 1 1 1 1 1 EPS (INR) basic -5-7 10 25 32 Loans and advances 50 48 91 91 91 EV/EBITDA (x) 15.8 22.3 8.9 7.5 6.3 Diluted shares (mn) 1 1 1 1 1 Other current assets 27 14 4 8 9 Diluted shares O/S 1 1 1 1 1 Cash EPS (INR) 4 3 20 35 43 Total current assets 502 576 658 705 783 Cash EPS 4 3 20 35 43 Dividend per share 0 0 0 1 1 Sundry creditors and others 207 281 306 340 378 Cash PE (x) 59 114.5 19.6 11 9 Dividend payout (%) 0 0 0 10 10 Provisions 1 1 4 4 4 Dividend yield (%) 0% 0% 0% 0% 0% Total CL & provisions 208 282 311 345 382 Common size metrics- as % of net revenues Net current assets 293 293 347 360 401 Year to March FY15 FY16 FY17 FY18E FY19E Net Deferred tax 0 0 0 0 0 Operating expenses 95 95 90 90 89 Misc expenditure 0 0 0 0 0 Depreciation 2 2 2 2 2 Uses of funds 485 480 519 542 582 Interest expenditure 5 6 5 4 3 Book value per share (INR) 247 241 251 274 305 EBITDA margins 5 5 10 10 11 Net profit margins NA NA 2 4 4 Opearting cash Flow Year to March FY15 FY16 FY17 FY18E FY19E Growth metrics (%) EBIT 15 15 63 76 91 Year to March FY15 FY16 FY17 FY18E FY19E Depriciation 12 13 13 14 15 Revenues -25 6 39 10 11 Tax -3-4 8 16 21 EBITDA -27 8 166 18 18 Chg in WC -58-1 65 19 29 PBT NA NA NA 48 29 CFO 88 34 4 55 56 Net profit after MI NA NA NA 151 29 EPS NA NA NA 151 29 4 GWM

Jan-13 Mar-13 May-13 Jul-13 Sep-13 Nov-13 Jan-14 Mar-14 May-14 Jul-14 Sep-14 Nov-14 Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Jan-16 Mar-16 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 Transformer and Rectifier (India) Ltd. Edelweiss Broking Limited, 1st Floor, Tower 3, Wing B, Kohinoor City Mall, Kohinoor City, Kirol Road, Kurla(W) Board: (91-22) 4272 2200 Vinay Khattar Head Research vinay.khattar@edelweissfin.com Rating Buy Hold Reduce Expected to appreciate more than 15% over a 12-month period appreciate between 5-15% over a 12-month period Return below 5% over a 12-month period 500 450 400 350 300 250 200 150 100 50 0 TRIL 5 years price chart 5 GWM

Disclaimer Edelweiss Broking Limited ( EBL or Research Entity ) is regulated by the Securities and Exchange Board of India ( SEBI ) and is licensed to carry on the business of broking, depository services and related activities. The business of EBL and its Associates (list available on www.edelweissfin.com) are organized around five broad business groups Credit including Housing and SME Finance, Commodities, Financial Markets, Asset Management and Life Insurance. Broking services offered by Edelweiss Broking Limited under SEBI Registration No.: INZ000005231; Name of the Compliance Officer: Mr. Dhirendra Rautela, Email ID: complianceofficer.ebl@edelweissfin.com Corporate Office: Edelweiss House, Off CST Road, Kalina, Mumbai - 400098; Tel. (022) 4009 4400/ 4088 5757/4088 6278 This Report has been prepared by Edelweiss Broking Limited in the capacity of a Research Analyst having SEBI Registration No.INH000000172 and distributed as per SEBI (Research Analysts) Regulations 2014. This report does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. The information contained herein is from publicly available data or other sources believed to be reliable. This report is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such investment. The investment discussed or views expressed may not be suitable for all investors. This information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject EBL and associates / group companies to any registration or licensing requirements within such jurisdiction. The distribution of this report in certain jurisdictions may be restricted by law, and persons in whose possession this report comes, should observe, any such restrictions. The information given in this report is as of the date of this report and there can be no assurance that future results or events will be consistent with this information. This information is subject to change without any prior notice. EBL reserves the right to make modifications and alterations to this statement as may be required from time to time. EBL or any of its associates / group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. EBL is committed to providing independent and transparent recommendation to its clients. Neither EBL nor any of its associates, group companies, directors, employees, agents or representatives shall be liable for any damages whether direct, indirect, special or consequential including loss of revenue or lost profits that may arise from or in connection with the use of the information. Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein. Past performance is not necessarily a guide to future performance.the disclosures of interest statements incorporated in this report are provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The information provided in these reports remains, unless otherwise stated, the copyright of EBL. All layout, design, original artwork, concepts and other Intellectual Properties, remains the property and copyright of EBL and may not be used in any form or for any purpose whatsoever by any party without the express written permission of the copyright holders. EBL shall not be liable for any delay or any other interruption which may occur in presenting the data due to any reason including network (Internet) reasons or snags in the system, break down of the system or any other equipment, server breakdown, maintenance shutdown, breakdown of communication services or inability of the EBL to present the data. In no event shall EBL be liable for any damages, including without limitation direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with the data presented by the EBL through this report. We offer our research services to clients as well as our prospects. Though this report is disseminated to all the customers simultaneously, not all customers may receive this report at the same time. We will not treat recipients as customers by virtue of their receiving this report. EBL and its associates, officer, directors, and employees, research analyst (including relatives) worldwide may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company(ies), mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company/company(ies) discussed herein or act as advisor or lender/borrower to such company(ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. EBL may have proprietary long/short position in the above mentioned scrip(s) and therefore should be considered as interested. The views provided herein are general in nature and do not consider risk appetite or investment objective of any particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation to do business with EBL. EBL or its associates may have received compensation from the subject company in the past 12 months. EBL or its associates may have managed or co-managed public offering of securities for the subject company in the past 12 months. EBL or its associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EBL or its associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EBL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report. Research analyst or his/her relative or EBL s associates may have financial interest in the subject company. EBL, its associates, research analyst and his/her relative may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. 6 GWM

Disclaimer Participants in foreign exchange transactions may incur risks arising from several factors, including the following: ( i) exchange rates can be volatile and are subject to large fluctuations; ( ii) the value of currencies may be affected by numerous market factors, including world and national economic, political and regulatory events, events in equity and debt markets and changes in interest rates; and (iii) currencies may be subject to devaluation or government imposed exchange controls which could affect the value of the currency. Investors in securities such as ADRs and Currency Derivatives, whose values are affected by the currency of an underlying security, effectively assume currency risk. Research analyst has served as an officer, director or employee of subject Company: No EBL has financial interest in the subject companies: No EBL s Associates may have actual / beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report. Research analyst or his/her relative has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No EBL has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No Subject company may have been client during twelve months preceding the date of distribution of the research report. There were no instances of non-compliance by EBL on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. A graph of daily closing prices of the securities is also available at www.nseindia.com Analyst Certification: The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. Additional Disclaimer for U.S. Persons Edelweiss is not a registered broker dealer under the U.S. Securities Exchange Act of 1934, as amended (the 1934 act ) and under applicable state laws in the United States. In addition Edelweiss is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Edelweiss, including the products and services described herein are not available to or intended for U.S. persons. This report does not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules. Transactions in securities discussed in this research report should be effected through Edelweiss Financial Services Inc. Additional Disclaimer for U.K. Persons The contents of this research report have not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 ("FSMA"). In the United Kingdom, this research report is being distributed only to and is directed only at (a) persons who have professional experience in matters relating to investments falling within Article 19(5) of the FSMA (Financial Promotion) Order 2005 (the Order ); (b) persons falling within Article 49(2)(a) to (d) of the Order (including high net worth companies and unincorporated associations); and (c) any other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as relevant persons ). This research report must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this research report relates is available only to relevant persons and will be engaged in only with relevant persons. Any person who is not a relevant person should not act or rely on this research report or any of its contents. This research report must not be distributed, published, reproduced or disclosed (in whole or in part) by recipients to any other person. 7 GWM

Disclaimer Additional Disclaimer for Canadian Persons Edelweiss is not a registered adviser or dealer under applicable Canadian securities laws nor has it obtained an exemption from the adviser and/or dealer registration requirements under such law. Accordingly, any brokerage and investment services provided by Edelweiss, including the products and services described herein, are not available to or intended for Canadian persons. This research report and its respective contents do not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services. Disclosures under the provisions of SEBI (Research Analysts) Regulations 2014 (Regulations) Edelweiss Broking Limited ("EBL" or "Research Entity") is regulated by the Securities and Exchange Board of India ("SEBI") and is licensed to carry on the business of broking, depository services and related activities. The business of EBL and its associates are organized around five broad business groups Credit including Housing and SME Finance, Commodities, Financial Markets, Asset Management and Life Insurance. There were no instances of non-compliance by EBL on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. This research report has been prepared and distributed by Edelweiss Broking Limited ("Edelweiss") in the capacity of a Research Analyst as per Regulation 22(1) of SEBI (Research Analysts) Regulations 2014 having SEBI Registration No.INH000000172. 8 GWM